Control releasing venlafaxine hydrochloride tablet and its prepn

A technology of venlafaxine hydrochloride and controlled-release tablets, which is used in pill delivery, pharmaceutical formulations, and medical preparations containing active ingredients, etc., can solve the problems of patients with large side effects, fluctuations in blood drug concentration, and poor compliance.

Active Publication Date: 2006-05-17
CHENGDU KANGHONG PHARMA GRP
View PDF0 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although sustained-release preparations have solved the problem of frequent dosing of the above-mentioned common preparations (only need to take medicine once a day), they can also reduce gastrointestinal side effects to a certain extent; The release and absorption rate of the drug is also affected by factors such as gastric juice or intestinal juice in the patient's body, which is difficul

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Control releasing venlafaxine hydrochloride tablet and its prepn
  • Control releasing venlafaxine hydrochloride tablet and its prepn

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0050] Example one

[0051] Venlafaxine hydrochloride controlled-release tablet preparation with a weight ratio of drug tablet core and semipermeable film coating of 1:0.035, wherein:

[0052] The composition of the drug tablet core is: 75 parts of venlafaxine hydrochloride, 114 parts of microcrystalline cellulose, 4 parts of sodium chloride, 6 parts of povidone K30, and 1 part of magnesium stearate.

[0053] The composition of the semipermeable film coating is: 9 parts of cellulose acetate, 0.78 parts of diethyl phthalate and 0.22 parts of polyethylene glycol 1500.

[0054] The preparation method of the above-mentioned venlafaxine hydrochloride controlled-release tablet preparation includes the following steps:

[0055] (1) Preparation of the drug tablet core: take the proportion of venlafaxine hydrochloride, microcrystalline cellulose, sodium chloride and povidone K30, mix well, add 95% ethanol solution to make a soft material, over 20 Mesh sieve granulation, drying at 50°C, siz...

Example Embodiment

[0059] Example two

[0060] Venlafaxine hydrochloride controlled-release tablet formulation with a weight ratio of drug tablet core and semipermeable film coating of 1:0.05, wherein:

[0061] The composition of the drug tablet core is: 75 parts of venlafaxine hydrochloride, 120 parts of microcrystalline cellulose, 1 part of sodium chloride, 15 parts of povidone K30 and 0.1 part of magnesium stearate.

[0062] The composition of the semipermeable film coating is 6 parts of cellulose acetate, 0.9 part of diethyl phthalate and 0.1 part of polyethylene glycol 1500.

[0063] The preparation method of the above-mentioned venlafaxine hydrochloride controlled-release tablet preparation includes the following steps:

[0064] (1) Preparation of drug tablet core: take the proportion of venlafaxine hydrochloride, microcrystalline cellulose, sodium chloride and povidone K30, mix them evenly, add 90% ethanol solution to make a soft material, over 20 Mesh sieve granulation, drying at 40°C, sizin...

Example Embodiment

[0068] Example three

[0069] Venlafaxine hydrochloride controlled-release tablet preparation with a weight ratio of drug tablet core and semipermeable film coating of 1:0.02, wherein:

[0070] The composition of the drug tablet core is: 75 parts of venlafaxine hydrochloride, 100 parts of microcrystalline cellulose, 30 parts of sodium chloride, 1 part of povidone K30 and 10 parts of magnesium stearate.

[0071] The composition of the semipermeable film coating is: 12 parts of cellulose acetate, 0.6 parts of diethyl phthalate and 0.4 parts of polyethylene glycol 1500.

[0072] The preparation method of the above-mentioned venlafaxine hydrochloride controlled-release tablet preparation includes the following steps:

[0073] (1) Preparation of the drug tablet core: take the proportion of venlafaxine hydrochloride, microcrystalline cellulose, sodium chloride and povidone K30, mix well, add 95% ethanol solution to make a soft material, over 20 Mesh sieve granulation, drying at 60℃, siz...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention discloses one kind of control releasing venlafaxine hydrochloride tablet and its preparation process. The control releasing venlafaxine hydrochloride tablet consists of medicine core of venlafaxine hydrochloride and semi-permeable coating with pores. The medicine core consists of venlafaxine hydrochloride 75 weight portions, stuffing 30-250 weight portions, osmotic pressure promoter 1-50 weight portions, adhesive 1-20 weight portions and lubricant 0.1-20 weight portions. The preparation has reasonable composition, excellent control releasing effect, long effective time, less side effect on gastrointestinal tract, less differential personal effect, high safety and good compliance.

Description

technical field [0001] The invention relates to the field of pharmaceutical preparations, in particular to a controlled-release tablet preparation of a novel antidepressant venlafaxine hydrochloride, and to a preparation method of the controlled-release tablet preparation. Background technique [0002] Venlafaxine is a new type of antidepressant, which has the remarkable characteristics of quick effect (4 days to 1 week), good tolerance, and good short-term and long-term therapeutic effects. At present, the venlafaxine preparations that have been marketed or reported at home and abroad include ordinary preparations and sustained-release preparations of different specifications, such as ordinary capsules, sustained-release tablets, sustained-release capsules and sustained-release pellets. However, venlafaxine in common preparations has problems such as short half-life (about 5±2 hours), frequent administration (2-3 times a day), and relatively large side effects. Although su...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/137A61K9/20A61P25/24
Inventor 潘卫三李威
Owner CHENGDU KANGHONG PHARMA GRP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap